News - Greater Bay Area International Clinical Trial Institute

03.11.2025

GBAICTI welcomes being included into Immigration Facilitation Scheme for Visitors Participating in Short-term Activities in Designated Sectors

The Greater Bay Area International Clinical Trial Institute (GBAICTI) welcomes being added by the Hong Kong Special Administrative Region (HKSAR) Government to the "Immigration Facilitation Scheme for Visitors Participating in Short-term Activities in Designated Sectors", becoming an authorized organization under the medical and healthcare sector. The new arrangement will take effect from November 1, 2025.

17.10.2025

GBAICTI Joins Key Medical Innovation Discussion in Macau

Professor Bernard Cheung, CEO of the GBAICTI, shared his expert vision for the future of regional medical research at the "Greater Bay Area Clinical Trial and Medical Innovation Forum" in Macau.

18.09.2025

GBAICTI Reaffirms Support for the Policy Address in Promoting the Development of the Life and Health Technology Industry

The 2025 Policy Address provides a powerful blueprint for Hong Kong's future as an international health and medical innovation hub, with a strategic focus on attracting companies to conduct clinical trials for rare diseases drugs, high-end cancer drugs, and advanced therapy products.

09.09.2025

GBAICTI, HKUMed and GSK signed the Tripartite Memorandum of Understanding

The Greater Bay Area International Clinical Trial Institute, the Department of Pharmacology and Pharmacy of the LKS Faculty of Medicine, The University of Hong Kong, and GSK signed a tripartite Memorandum of Understanding. The three parties jointly established a strategic framework to advance clinical data and real-world studies in the Greater Bay Area.

22.08.2025

GBAICTI and Bay Trial Advanced Collaborative Efforts in Strategic Meeting

GBAICTI and Bay Trial held a regular meeting to advance their collaborative platform, focusing on the practical implementation of talent exchange, joint branding, and knowledge-sharing initiatives to jointly promote clinical research development in the GBA.

19.08.2025

GBAICTI Showcased Hong Kong's Clinical Trial Strengths to Visiting Greater Bay Area Biomedical Delegation

GBAICTI presented Hong Kong's unique clinical trial advantages to a delegation of over 30 biomedical enterprise representatives from the Greater Bay Area, fostering cross-border collaboration in medical innovation.